PARP1 and Alzheimer disease: In the present study we focused on the comprehension of the molecular mechanisms that lead to PARP-1 activation by Aβ in SH-SY5Y neuroblastoma derived cells and in transgenic mice TgCRND8, an early onset model of AD and to the downstream ways activated by PARP-1.